signal/raiseTrack rounds
SeedHealthtech & bio · Murray Hill

AstraNu raises $3.5m seed round led by Celesta Capital for chip-scale OCT imaging

The Nokia Bell Labs spin-out plans to put its miniature swept-source imaging engine into partner medical devices, starting with eye care. New Jersey's state innovation fund co-invested.

s/rFunding deskNorth America · 3 min read

AstraNu, a medical imaging hardware company based in Murray Hill, New Jersey, said on 17 November 2026 that it had closed a $3.5m seed round led by Celesta Capital.

The New Jersey Innovation Evergreen Fund, a programme run by the New Jersey Economic Development Authority, co-invested in the round. The company did not disclose a valuation, its headcount or any revenue.

AstraNu was spun out of Nokia Bell Labs in May 2025 with backing from Celesta. It was the first company to come out of a partnership between Nokia and the venture firm to turn Bell Labs research into businesses.

“This funding enables us to drive our strategy forward by building out our photonics development team and manufacturing readiness ahead of customer volume.”Kevin Blalock, President and General Manager, AstraNu

What AstraNu makes

The company builds an imaging engine for optical coherence tomography, or OCT, a technique that uses light to produce cross-sectional images of tissue and is widely used to examine the retina. AstraNu does not plan to sell finished instruments. Instead it supplies the engine to medical device, imaging and optics companies that want to build OCT into their own products.

Its engine is based on swept-source OCT, which uses a light source whose wavelength can be tuned. AstraNu said this approach can image faster and deeper than the older spectral-domain method, but that cost and size have so far held back its use. The company said its module is more than ten times smaller than conventional swept-source systems and costs much less, putting it close to the price of spectral-domain equipment.

Ophthalmology is the first commercial target because it is the largest current market for OCT. AstraNu said it is also working with developers of products in ear, nose and throat care, urology and oncology. When the company was launched in 2025, Celesta said its first focus would be imaging the middle ear to help diagnose hearing problems.

What the money is for

AstraNu said it would spend the seed funding on hiring a photonics development team, on validating how its engine performs and on getting ready for volume manufacturing. Kevin Blalock, its president and general manager, said the money would let the company place the engine in partner testbeds.

The company said it had already reached swept-source performance at chip scale and was ready to demonstrate the engine with application partners. It has not announced customers committed to production, regulatory clearances, clinical results or pricing, as the UK trade site inelectronics.co.uk noted in its report on the round. The site also pointed out that device makers will need to do further work on optics, power, temperature control and software before the engine can be used in a finished product.

Who is backing it

Celesta Capital is a venture firm that has invested since 2013 in semiconductors, intelligent hardware and other deep technology. Matthew Marsh, its managing partner and chief financial officer, said the firm looks for basic technology from major research labs that can open up large, established markets, and that scaling such technology into volume production needs disciplined operations and commercial partners.

Nokia Bell Labs, where the core technology was developed, has continued to support the company with laboratory resources and research expertise, according to Celesta's 2025 launch announcement. That announcement named Trevor Hawkins as chief executive at the time and said the technology's co-inventors, Michael Eggleston and Bibek Samanta, would support the company. The new release names Blalock as the executive leading the business.

AstraNu said medical device, imaging and optics companies can now contact it to evaluate the engine.

Company website: astranu.com